Cannabinoids have also been documented to downregulate androgen receptor expression and prostate specific antigen (PSA) [148]; however, the sensitivity to cannabinoids seems to be inconsistent in different prostate cancer cell lines, even in the presence of CB receptors [128, 147, 148]. This evidence concerns the gene KLK3 and Familial prostate cancer.